These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6302493)

  • 1. Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor.
    Newsom-Davis J; Murray N; Wray D; Lang B; Prior C; Gwilt M; Vincent A
    Muscle Nerve; 1982; 5(9S):S17-20. PubMed ID: 6302493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.
    Prior C; Lang B; Wray D; Newsom-Davis J
    Ann Neurol; 1985 Jun; 17(6):587-92. PubMed ID: 2992356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate.
    Fukuoka T; Engel AG; Lang B; Newsom-Davis J; Vincent A
    Ann Neurol; 1987 Aug; 22(2):200-11. PubMed ID: 3310854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambert-Eaton myasthenic syndrome: a review.
    Newsom-Davis J
    Monogr Allergy; 1988; 25():116-24. PubMed ID: 2845259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Springer Semin Immunopathol; 1985; 8(1-2):129-40. PubMed ID: 2988146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.
    Lang B; Vincent A; Murray NM; Newsom-Davis J
    Ann Neurol; 1989 Mar; 25(3):265-71. PubMed ID: 2543262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular transmission in nude mice bearing oat cell tumors from Lambert-Eaton myasthenic syndrome.
    Lambert EH; Lennon VA
    Muscle Nerve; 1982; 5(9S):S39-45. PubMed ID: 6302495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
    Flink MT; Atchison WD
    J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation.
    Nagel A; Engel AG; Lang B; Newsom-Davis J; Fukuoka T
    Ann Neurol; 1988 Oct; 24(4):552-8. PubMed ID: 2853605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient Lambert-Eaton myasthenic syndrome associated with systemic lupus erythematosus.
    Bromberg MB; Albers JW; McCune WJ
    Muscle Nerve; 1989 Jan; 12(1):15-9. PubMed ID: 2747733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating T cell subsets in the Lambert-Eaton myasthenic syndrome.
    Robb SA; Bowley TJ; Willcox HN; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1985 Jun; 48(6):501-5. PubMed ID: 2989435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
    Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
    J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones.
    Fukuoka T; Engel AG; Lang B; Newsom-Davis J; Prior C; Wray DW
    Ann Neurol; 1987 Aug; 22(2):193-9. PubMed ID: 3662451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.
    Lang B; Newsom-Davis J; Prior C; Wray D
    J Physiol; 1983 Nov; 344():335-45. PubMed ID: 6655585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
    Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
    Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.